PCIG
EW icon

Partners Capital Investment Group’s Edwards Lifesciences EW Stock Holding History

Partners Capital Investment Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,481
Closed -$671K – 141
2021
Q2 		$671K Sell
6,481
-16,544
-72% -$1.56M 0.03% 125
2021
Q1 		$1.93M Buy
+23,025
New +$1.95M 0.08% 116

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Partners Capital Investment Group's EW Position: Q3 2021 in Review

Partners Capital Investment Group sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 6,481 shares — an estimated $671K sold.

Partners Capital Investment Group first reported a position in EW in Q1 2021 and held it in 2 quarters. The position peaked at $1.93M in Q1 2021. 1,227 funds tracked by Wall St. Rank hold EW as of Q3 2021.

  • Partners Capital Investment Group reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
  • Partners Capital Investment Group sold 6,481 Edwards Lifesciences shares in Q3 2021, an estimated $671K.
  • Partners Capital Investment Group first reported a position in Edwards Lifesciences in Q1 2021 and held it in 2 quarters.
  • Partners Capital Investment Group's Edwards Lifesciences position peaked at $1.93M in Q1 2021.
  • 1,227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Partners Capital Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.